Luis C. Pena

Luis C. Pena discloses dealings in 2 companies, chiefly Dermira, Inc. and Evommune, Inc. The record holds 33 filings, for trades running from 15 June 2016 to 30 September 2026.

Sales make up the whole of the open-market record (4 sales, €855k). The rest of the record consists of 12 share grants and 15 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

The newest entry dates from 15 October 2026: a share grant of €6,900, in Evommune, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.